Mel vs. Edluar: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Mel and Edluar. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 184,029 people who take Mel and Edluar, and is updated regularly.
What is Mel?
Mel has active ingredients of honey. It is often used in insomnia. eHealthMe is studying from 72 Mel users. Check the latest studies of Mel.
What is Edluar?
Edluar has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 157 Edluar users. Check the latest studies of Edluar.
184,029 people who take Mel and Edluar are studied.
Drugs being compared in this study:
- Mel (honey)
- Edluar (zolpidem tartrate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Mel:
- not at all: 13.4 %
- somewhat: 9.28 %
- moderate: 43.3 %
- high: 27.84 %
- very high: 6.19 %
Edluar:
- not at all: 2.07 %
- somewhat: 16.14 %
- moderate: 31.96 %
- high: 34.33 %
- very high: 15.51 %
Want to compare Mel with Edluar?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Mel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Edluar:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on honey and zolpidem tartrate (the active ingredients of Mel and Edluar, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rheumatoid Arthritis and drugs of ingredients of amitriptyline hydrochloride - 11 seconds ago
- Tri-Luma and Rashes for Women aged 40-49 - 15 seconds ago
- Tri-Luma and Rash Generalised for Women aged 40-49 - 15 seconds ago
- Tri-Luma and Rash for Women aged 40-49 - 15 seconds ago
- Tri-Luma and Skin Redness Or Inflammation for Women aged 40-49 - 15 seconds ago
- Tri-Luma and Skin Lesion for Women aged 40-49 - 16 seconds ago
- Tri-Luma and Rubor for Women aged 40-49 - 16 seconds ago
- Tri-Luma and Erythema for Women aged 40-49 - 16 seconds ago
- Tri-Luma and Skin Rash for Women aged 40-49 - 17 seconds ago
- Drug interactions of Hydromorphone Hydrochloride and Plavix - 17 seconds ago